scispace - formally typeset
C

Camille C. Andre

Researcher at University of Rochester

Publications -  6
Citations -  253

Camille C. Andre is an academic researcher from University of Rochester. The author has contributed to research in topics: Type 1 diabetes & Artificial pancreas. The author has an hindex of 4, co-authored 5 publications receiving 165 citations.

Papers
More filters
Journal ArticleDOI

Design and Clinical Evaluation of the Interoperable Artificial Pancreas System (iAPS) Smartphone App: Interoperable Components with Modular Design for Progressive Artificial Pancreas Research and Development

TL;DR: The interoperable artificial pancreas system (iAPS) smartphone app that can interface wirelessly with leading continuous glucose monitors (CGM), insulin pump devices, and decision-making algorithms while running on an unlocked smartphone was safe and effective in regulating glucose levels under challenging conditions and is suitable for use in unconstrained environments.
Journal ArticleDOI

Evaluation of an Artificial Pancreas with Enhanced Model Predictive Control and a Glucose Prediction Trust Index with Unannounced Exercise.

TL;DR: It is concluded that eMPC with trust index AP achieved nearly 90% time in the target glucose range and enhanced controller responsiveness to predicted hyper- and hypoglycemia by 26%.
Journal ArticleDOI

The Effect of Two Types of Pasta Versus White Rice on Postprandial Blood Glucose Levels in Adults with Type 1 Diabetes: A Randomized Crossover Trial

TL;DR: This exploratory study concluded that different food types of similar macronutrient content (e.g., rice and pasta) generate significantly different postprandial glycemic responses in persons with T1D.
Journal ArticleDOI

Randomized Crossover Comparison of Automated Insulin Delivery Versus Conventional Therapy Using an Unlocked Smartphone with Scheduled Pasta and Rice Meal Challenges in the Outpatient Setting

TL;DR: The iAPS interoperable artificial pancreas system running on an unlocked smartphone improved postprandial glucose control over conventional therapy in the setting of challenging meals in the outpatient setting.